» Articles » PMID: 31763494

Creating an Academic Research Organization to Efficiently Design, Conduct, Coordinate, and Analyze Clinical Trials: The Center for Clinical Trials & Data Coordination

Overview
Date 2019 Nov 26
PMID 31763494
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

When properly executed, the randomized controlled trial is one of the best vehicles for assessing the effectiveness of one or more interventions. However, numerous challenges may emerge in the areas of study startup, recruitment, data quality, cost, and reporting of results. The use of well-run coordinating centers could help prevent these issues, but very little exists in the literature describing their creation or the guiding principles behind their inception. The Center for Clinical Trials & Data Coordination (CCDC) was established in 2015 through institutional funds with the intent of 1) providing relevant expertise in clinical trial design, conduct, coordination, and analysis; 2) advancing the careers of clinical investigators and CCDC-affiliated faculty; and 3) obtaining large data coordinating center (DCC) grants. We describe the organizational structure of the CCDC as well as the homegrown clinical trial management system integrating nine crucial elements: electronic data capture, eligibility and randomization, drug and external data tracking, safety reporting, outcome adjudication, data and safety monitoring, statistical analysis and reporting, data sharing, and regulatory compliance. Lastly, we share numerous lessons that can be taken from our experience. Specifically, we focus on 1) funding for DCCs, 2) the importance of DCCs to clinical researchers, 3) the expertise of DCC personnel, and 4) continually striving to improve. In conclusion, the CCDC strives to provide high-quality support for the design, conduct, coordination, and analyses of clinical trials, and we hope this paper will serve as a blueprint for future clinical trialists involved in DCCs.

Citing Articles

Human versus Analogue Insulin for Youth with Type 1 Diabetes in Low-Resource Settings (HumAn-1): protocol for a randomised controlled trial.

Foulds A, Josey C, Kehlenbrink S, Rollman B, Chang C, Lalama C BMJ Open. 2025; 15(1):e092432.

PMID: 39890140 PMC: 11795411. DOI: 10.1136/bmjopen-2024-092432.


Misleading Reporting (Spin) in Noninferiority Randomized Clinical Trials in Oncology With Statistically Not Significant Results: A Systematic Review.

Ito C, Hashimoto A, Uemura K, Oba K JAMA Netw Open. 2021; 4(12):e2135765.

PMID: 34874407 PMC: 8652604. DOI: 10.1001/jamanetworkopen.2021.35765.

References
1.
Venet D, Doffagne E, Burzykowski T, Beckers F, Tellier Y, Genevois-Marlin E . A statistical approach to central monitoring of data quality in clinical trials. Clin Trials. 2012; 9(6):705-13. DOI: 10.1177/1740774512447898. View

2.
Brown S, Sherratt D, Booth G, Brown J, Collinson F, Gregory W . Experiences of establishing an academic early phase clinical trials unit. Clin Trials. 2017; 14(4):349-356. DOI: 10.1177/1740774517710250. View

3.
Kirkwood A, Cox T, Hackshaw A . Application of methods for central statistical monitoring in clinical trials. Clin Trials. 2013; 10(5):783-806. DOI: 10.1177/1740774513494504. View

4.
Schrier R, Abebe K, Perrone R, Torres V, Braun W, Steinman T . Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med. 2014; 371(24):2255-66. PMC: 4343258. DOI: 10.1056/NEJMoa1402685. View

5.
Croghan I, Viker S, Limper A, Evans T, Cornell A, Ebbert J . Developing a clinical trial unit to advance research in an academic institution. Contemp Clin Trials. 2015; 45(Pt B):270-276. DOI: 10.1016/j.cct.2015.10.001. View